CAP Antibiotics May Not Benefit Nonsevere COVID-19 Infections

Patients hospitalized with nonsevere COVID-19 infections who received empiric antibiotics targeting community-acquired pneumonia may not experience clinically meaningful improvement in outcomes and could have a slightly increased risk of clinical deterioration or in-hospital mortality.